Lois W. Dow

1.6k total citations
32 papers, 1.3k citations indexed

About

Lois W. Dow is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Lois W. Dow has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 13 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Lois W. Dow's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Lois W. Dow is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Lois W. Dow collaborates with scholars based in United States, United Kingdom and Canada. Lois W. Dow's co-authors include A Bank, P A Marks, Salvatore Metafora, M Terada, S. Spiegelman, Daniel Kacian, A. Thomas Look, Philip J. Fialkow, Robert J. Jacobson and Wendy H. Raskind and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Lois W. Dow

32 papers receiving 1.2k citations

Peers

Lois W. Dow

HEMAT

GENET

PHEOH

ONCOL

Yataro Yoshida Japan

Inge Høgh Dufva Denmark

Rodman Morgan United States

Bertil Casslén Sweden

Shunji Yamamori Japan

U Haglund Sweden

Ravindran Ankathil Malaysia

Marie-Christine Rouyez France

F. M. Sirotnak United States

Alexandra E. Irvine United Kingdom

Yataro Yoshida Japan

Lois W. Dow

664 ×1.1

HEMAT

404 ×0.7

194 ×0.5

GENET

114 ×0.4

PHEOH

177 ×0.7

ONCOL

Citations per year, relative to Lois W. Dow Lois W. Dow (= 1×) peers Yataro Yoshida

Countries citing papers authored by Lois W. Dow

Since Specialization

Citations

This map shows the geographic impact of Lois W. Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois W. Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois W. Dow more than expected).

Fields of papers citing papers by Lois W. Dow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois W. Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois W. Dow. The network helps show where Lois W. Dow may publish in the future.

Co-authorship network of co-authors of Lois W. Dow

This figure shows the co-authorship network connecting the top 25 collaborators of Lois W. Dow. A scholar is included among the top collaborators of Lois W. Dow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois W. Dow. Lois W. Dow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wilimas, Judith A., Lois W. Dow, Edwin C. Douglass, et al.. (1991). Evidence for Clonal Development of Wilmsʼ Tumor. Journal of Pediatric Hematology/Oncology. 13(1). 26–28. 9 indexed citations

Dow, Lois W., et al.. (1991). Response to alpha-interferon in children with Philadelphia chromosome-positive chronic myelocytic leukemia. Cancer. 68(8). 1678–1684. 28 indexed citations

Papayannopoulou, Thalia, et al.. (1991). Expression of embryonic globins by erythroid cells in juvenile chronic myelocytic leukemia. Blood. 77(12). 2569–2576. 2 indexed citations

Weir, Alva B. & Lois W. Dow. (1989). Response of agranulocytosis to thymectomy in a patient with thymoma and chronic lymphocytic leukemia. Medical and Pediatric Oncology. 17(1). 58–61. 13 indexed citations

Raimondi, Susana C., et al.. (1988). Cytogenetic evidence for involvement of erythroid and granulocyte/macrophage progenitors in an infant with monosomy 7 syndrome presenting de novo. Medical and Pediatric Oncology. 16(2). 118–122. 3 indexed citations

Clark, Steven S., Jami McLaughlin, Ann Marie Pendergast, et al.. (1988). Expression of a Distinctive BCR-ABL Oncogene in Ph ¹ -Positive Acute Lymphocytic Leukemia (ALL). Science. 239(4841). 775–777. 205 indexed citations

Dow, Lois W., Joseph Mirro, Gary V. Dahl, et al.. (1987). Comparison of two clonogenic assays for determining cell growth patterns in childhood acute myeloid leukemia: Relationships to clinical findings and prognosis. Leukemia Research. 11(6). 565–573. 3 indexed citations

Weiss, K, Sanford A. Stass, Diane L. Williams, et al.. (1987). Childhood monosomy 7 syndrome: clinical and in vitro studies.. PubMed. 1(2). 97–104. 35 indexed citations

Fialkow, Philip J., Jack W. Singer, Wendy H. Raskind, et al.. (1987). Clonal Development, Stem-Cell Differentiation, and Clinical Remissions in Acute Nonlymphocytic Leukemia. New England Journal of Medicine. 317(8). 468–473. 241 indexed citations

10.

Shannon, Kevin, Gabriel Núñez, Lois W. Dow, et al.. (1986). Juvenile Chronic Myelogenous Leukemia: Surface Antigen Phenotyping by Monoclonal Antibodies and Cytogenetic Studies. PEDIATRICS. 77(3). 330–335. 11 indexed citations

11.

Rivera, Gaston K., William E. Evans, David K. Kalwinsky, et al.. (1985). Unexpectedly severe toxicity from intensive early treatment of childhood lymphoblastic leukemia.. Journal of Clinical Oncology. 3(2). 201–206. 32 indexed citations

12.

Melvin, Susan L., et al.. (1985). Transient myeloproliferative syndrome in a phenotypically normal infant.. PubMed. 7(1). 79–81. 27 indexed citations

13.

Dow, Lois W., J A Sinkule, A. Thomas Look, Attila Horváth, & William E. Evans. (1983). Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.. PubMed. 43(12 Pt 1). 5699–706. 40 indexed citations

14.

Sinkule, J A, et al.. (1982). Pharmacokinetics of teniposide (VM26) and etoposide (VP16-213) in children with cancer. Cancer Chemotherapy and Pharmacology. 7(2-3). 147–50. 95 indexed citations

15.

Parmley, Richard T., Samuel S. Spicer, Atsushi Komiyama, Lois W. Dow, & Ronald L. Austin. (1979). Ultrastructural cytochemistry of basophils in chronic myelocytic leukemia. Experimental and Molecular Pathology. 30(1). 41–54. 11 indexed citations

16.

Bank, A, et al.. (1973). Changes in Globin Synthesis With Erythroid Cell Maturation in Sickle Thalassemia. Blood. 41(3). 353–357. 26 indexed citations

17.

Kacian, Daniel, Roberto Gambino, Lois W. Dow, et al.. (1973). Decreased Globin Messenger RNA in Thalassemia Detected by Molecular Hybridization. Proceedings of the National Academy of Sciences. 70(6). 1886–1890. 95 indexed citations

18.

Grossbard, Elliott B., Masaaki Terada, Lois W. Dow, & Arthur Bank. (1973). Decreased α Globin Messenger RNA Activity associated with Polyribosomes in α Thalassaemia. Nature New Biology. 241(111). 209–211. 19 indexed citations

19.

Terada, M, Salvatore Metafora, J. Banks, et al.. (1972). Conservation of globin messenger RNA in rabbit reticulocyte monoribosomes after sodium fluoride treatment. Biochemical and Biophysical Research Communications. 47(4). 766–774. 32 indexed citations

20.

Metafora, Salvatore, M Terada, Lois W. Dow, P A Marks, & A Bank. (1972). Increased Efficiency of Exogenous Messenger RNA Translation in a Krebs Ascites Cell Lysate. Proceedings of the National Academy of Sciences. 69(5). 1299–1303. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact